Clinical Trial Update: Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating fenofibrate in patients with compensated cirrhosis due to primary biliary cholangitis and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis
• Cirrhosis

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cholangitis | Phase 2, Phase 3 | Status: RECRUITING